AMITIZA Trademark

Trademark Overview


On Wednesday, August 24, 2005, a trademark application was filed for AMITIZA with the United States Patent and Trademark Office. The USPTO has given the AMITIZA trademark a serial number of 78699418. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, February 6, 2016. This trademark is owned by Sucampo Pharmaceuticals, Inc.. The AMITIZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases
amitiza

General Information


Serial Number78699418
Word MarkAMITIZA
Filing DateWednesday, August 24, 2005
Status800 - REGISTERED AND RENEWED
Status DateSaturday, February 6, 2016
Registration Number3170145
Registration DateTuesday, November 7, 2006
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 1, 2005
Primary Code005
First Use Anywhere DateMonday, April 3, 2006
First Use In Commerce DateMonday, April 3, 2006

Trademark Owner History


Party NameSUCAMPO AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address6300 Zug
CH

Party NameSucampo Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Party NameSucampo Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Party NameSucampo Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814

Trademark Events


Event DateEvent Description
Thursday, September 1, 2005NEW APPLICATION ENTERED
Sunday, March 12, 2006ASSIGNED TO EXAMINER
Monday, March 13, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, March 13, 2006EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, March 14, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 4, 2006ASSIGNED TO LIE
Tuesday, April 11, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 10, 2006NOTICE OF PUBLICATION
Tuesday, May 30, 2006PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 29, 2006TEAS STATEMENT OF USE RECEIVED
Tuesday, August 29, 2006USE AMENDMENT FILED
Wednesday, September 20, 2006STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 21, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 2, 2006ASSIGNED TO LIE
Tuesday, October 3, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, November 7, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 18, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 20, 2012TEAS SECTION 8 & 15 RECEIVED
Saturday, May 5, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 5, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 5, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 7, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 20, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, February 6, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, February 6, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, February 6, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, February 6, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, November 7, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED